+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Thyroid Function Test Market by Test Type and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • PDF Icon

    Report

  • 206 Pages
  • March 2020
  • Region: Global
  • Allied Market Research
  • ID: 5031463
The global thyroid function test market was valued at $1,190 million in 2018, and is projected to reach $1,807 million by 2026, registering a CAGR of 5.3% from 2019 to 2026.



Thyroid function test involves a series of blood tests used to measure adequacy of the levels of thyroid hormones. These blood tests can define whether the thyroid hormone production is normal, overactive, or underactive. It involves the different types of tests such as T3, T4, TSH, and T3RU.
The thyroid function test market is expected to witness significant growth during the forecast period owing to increase in The prevalence of thyroid disorders, rise in awareness for early screening of disease, and wide presence of advanced diagnostic laboratories. In addition, early detection of the disease, increase in number of geriatric population, and a rise in the number of awareness campaigns in developing countries support the market growth. However, lack of insurance coverage for thyroid testing hampers the market growth.

The global thyroid function test market is segmented into test type, end user, and region. By test type, the market is classified into TSH tests, T3 tests, T4 TESTS, and others. According to end user, it is categorized into hospitals, diagnostic laboratories, and others. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Test type
  • TSH Tests
  • T3 Tests
  • T4 Tests
  • Other Tests

By End user
  • Diagnostic Laboratories
  • Hospitals
  • Others

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Abbott Laboratories
  • Biomerieux
  • Danaher Corporation
  • Diagnostic Automation/Cortez Diagnostics Inc.
  • DiaSorin
  • F. Hoffmann-La Roche AG
  • KRONUS
  • Merck KGaA
  • Qualigen Inc.
  • Thermo Fisher Scientific

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
  • Cortez Diagnostics
  • Autobio Diagnostics

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. Key findings
2.2.1. Top investment pockets
2.2.2. Market player positioning, 2018
2.3. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key forces shaping thyroid function test industry/market
3.2.1. Moderate power of suppliers
3.2.2. High threat of new entrants
3.2.3. High threat of substitution
3.2.4. Moderate competitive rivalry
3.2.5. Moderate bargaining power of buyers
3.3. Market dynamics
3.3.1. Drivers
3.3.1.1. Increase in The prevalence of thyroid disorders
3.3.1.2. Increase in number of geriatric population
3.3.1.3. Surge in healthcare expenditure worldwide
3.3.2. Restraint
3.3.2.1. Lack of awareness in under developed nations
3.3.3. Opportunities
3.3.3.1. Growth opportunities in emerging markets
3.3.4. Impact analysis
CHAPTER 4: THYROID FUNCTION TEST MARKET, BY TEST TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. TSH tests
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. T3 Tests
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. T4 tests
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Others
4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
CHAPTER 5: THYROID FUNCTION TEST MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Diagnostic Laboratories
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Hospitals
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Others
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
CHAPTER 6: THYROID FUNCTION TEST MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U. S.
6.2.2.1.1. U. S. thyroid function test market, by test type
6.2.2.1.2. U. S. thyroid function test market, by end user
6.2.2.2. Canada
6.2.2.2.1. Canada thyroid function test market, by test type
6.2.2.2.2. Canada thyroid function test market, by end user
6.2.2.3. Mexico
6.2.2.3.1. Mexico thyroid function test market, by test type
6.2.2.3.2. Mexico thyroid function test market, by end user
6.2.3. North America market size and forecast, by test type
6.2.4. North America thyroid function test market, by end user
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany thyroid function test market, by test type
6.3.2.1.2. Germany thyroid function test market, by end user
6.3.2.2. France
6.3.2.2.1. France thyroid function test market, by test type
6.3.2.2.2. France thyroid function test market, by end user
6.3.2.3. UK
6.3.2.3.1. UK thyroid function test market, by test type
6.3.2.3.2. UK thyroid function test market, by end user
6.3.2.5. Italy
6.3.2.5.1. Italy thyroid function test market, by test type
6.3.2.5.2. Italy thyroid function test market, by end user
6.3.2.6. Spain
6.3.2.6.1. Spain thyroid function test market, by test type
6.3.2.6.2. Spain thyroid function test market, by end user
6.3.2.7. Rest of Europe
6.3.2.7.1. Rest of Europe thyroid function test market, by test type
6.3.2.7.2. Rest of Europe thyroid function test market, by end user
6.3.3. Europe market size and forecast, by test type
6.3.4. Europe thyroid function test market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan thyroid function test market, by test type
6.4.2.1.2. Japan thyroid function test market, by end user
6.4.2.2. China
6.4.2.2.1. China thyroid function test market, by test type
6.4.2.2.2. China thyroid function test market, by end user
6.4.2.3. Australia
6.4.2.3.1. Australia thyroid function test market, by test type
6.4.2.3.2. Australia thyroid function test market, by end user
6.4.2.5. India
6.4.2.5.1. India thyroid function test market, by test type
6.4.2.5.2. India thyroid function test market, by end user
6.4.2.6. South Korea
6.4.2.6.1. South Korea thyroid function test market, by test type
6.4.2.6.2. South Korea thyroid function test market, by end user
6.4.2.7. Rest of Asia-Pacific
6.4.2.7.1. Rest of Asia-Pacific thyroid function test market, by test type
6.4.2.7.2. Rest of Asia-Pacific thyroid function test market, by end user
6.4.3. Asia-Pacific market size and forecast, by test type
6.4.4. Asia-Pacific thyroid function test market, by end user
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil thyroid function test market, by test type
6.5.2.1.2. Brazil thyroid function test market, by end user
6.5.2.3. Saudi Arabia
6.5.2.3.1. Saudi Arabia thyroid function test market, by test type
6.5.2.3.2. Saudi Arabia thyroid function test market, by end user
6.5.2.4. South Africa
6.5.2.4.1. South Africa thyroid function test market, by test type
6.5.2.4.2. South Africa thyroid function test market, by end user
6.5.2.5. Rest of LAMEA
6.5.2.5.1. Rest of LAMEA thyroid function test market, by test type
6.5.2.5.2. Rest of LAMEA thyroid function test market, by end user
6.5.3. LAMEA market size and forecast, by test type
6.5.4. LAMEA thyroid function test market, by end user
CHAPTER 7: COMPANY PROFILES
7.1. Abbott Laboratories
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. Biomerieux
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. Danaher Corporation
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.4. Diagnostic Automation/Cortez Diagnostics Inc.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.5. DiaSorin
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. F. Hoffmann-La Roche AG
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. KRONUS
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.8. Merck KGaA
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. Qualigen Inc.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.10. ThermoFisher Scientific
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance

Executive Summary

According to this report titled, 'Thyroid Function Test Market by Test Type, and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026,' the global thyroid function test market size was valued at $1,190 million in 2018, and is projected to reach $1,807million by 2026, growing at a CAGR of 5.3% from 2019 to 2026.

Thyroid produces hormones such as triiodothyronine (T3), and thyroxine (T4) which are responsible in production and regulation of the hormones such as adrenaline and dopamine. Hence, the underproduction, and overproduction of these hormones can lead serious health deteriorations. Therefore, thyroid function test involves series of blood tests such as T3, T4, TSH, T3RU, and others to diagnose the functioning of thyroid gl ands. These blood tests can define whether the thyroid hormone production is normal, overactive, or underactive.

The global thyroid function test market is expected to exhibit significant growth during the forecast period, owing to an increase in The prevalence of thyroid disorders. For instance, approximately, 20 million Americans are suffering from some form of thyroid disease, and up to 60% of those with thyroid disease are unaware of their condition. In addition, factors such as increase in awareness for early screening of disease, and presence of advanced diagnostic laboratories also fuel the growth of thyroid function test market. Furthermore, early detection of the disease, increase in number of geriatric population, and a rise in the number of awareness campaigns in developing countries further support the market growth of thyroid function test market. However, lack of insurance coverage for thyroid testing hampers the market growth. Conversely, growth potential exhibited by developing countries provide lucrative opportunities during the forecast period.

The global thyroid function test market is segmented into test type, end user, and region. On the basis of test type, the market is classified into TSH tests, T3 tests, T4 tests, and others. According to end user, the market is categorized into hospitals, diagnostic laboratories, and others. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA)

Depending on test type, the market is divided into TSH tests, T3 tests, T4 tests, and others. The TSH tests is the major revenue contributor, and is expected to show significant growth during the forecast period, due to preferable usage of TSH tests for preliminary screening of the disease and a rise in target population. Furthermore, according to the Office on Women's Health, 1 in 8 females experience thyroid problems at some point, which is expected to drive the demand for TSH tests, thereby augmenting the growth of the global market.

According to end user, the diagnostic laboratories segment accounted for the highest revenue in 2018, and is anticipated to dominate the market during the forecast period. This is attributed to large presence with higher preference for diagnostic laboratories for thyroid testing. Furthermore, hospitals segment is expected to grow with the highest CAGR during the forecast period owing to surge in awareness related to early diagnosis of disorders related to thyroid function. In addition, factors such as a rise in the number of specialized hospitals and surge in healthcare expenditure across the globe are other major factors that contribute to the growth of the market.

According to Onkar Sumant, Manager, Healthcare, “The growth of the global thyroid function testmarket is majorly driven by rise in The prevalence ofthyroid disorders across the globe. Furthermore, increase in awareness of early screening of the disease and a rise in geriatric population significantly contribute toward the growth of the market.”

KEY FINDINGS OF THE STUDY
  • Depending on test type, the TSH tests segment held more than one-third of the share in the global market in 2018.
  • By end user, the hospitals segment exhibits fastest growth, and is expected to grow at a CAGR of 6.1% from 2019 to 2026.
  • Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.6% during the forecast period.

North America accounted for approximately one-half of the global thyroid function test market share in 2018, and is expected to remain dominant throughout the forecast period. This was attributed to higher adoption of ideal thyroid function test, presence of large number of target population coupled with rise in health awareness, availability of trained medical professionals, and supportive reimbursement policies in the healthcare system. On the contrary, Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to surge in the prevalence of thyroid disorders along with increase in adoption of thyroid function tests.

Companies Mentioned

  • Abbott Laboratories
  • Biomerieux
  • Danaher Corporation
  • Diagnostic Automation/Cortez Diagnostics Inc.
  • DiaSorin
  • F. Hoffmann-La Roche AG
  • KRONUS
  • Merck KGaA
  • Qualigen Inc.
  • ThermoFisher Scientific

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information